Teva Pharmaceutical ( Teva Pharmaceutical )

Teva Pharmaceutical

Teva Pharmaceutical's picture

The foundation of our success, and at the heart of Teva, is our vision to be the most indispensable medicines company for the world, executing on our obligation to our patients, customers, shareholders and employees.

Established in 1901, today we rank among the 10 top pharmaceutical companies in the world. Headquartered in Israel, Teva is active in 60 countries, with over 46,400 dedicated employees worldwide.

Teva Pharmaceutical press release, blog etc

01/04/2018 - 08:25 Teva to Present at the 36th Annual J.P. Morgan Healthcare Conference
01/02/2018 - 14:20 Teva Announces Launch of an Authorized Generic of Estrace Cream in the United States
12/27/2017 - 07:06 Teva Announces Exclusive Launch of a Generic Version of Reyataz in the United States
12/18/2017 - 11:59 FDA Accepts Biologics License Application for Fremanezumab with Priority Review for Prevention of Migraine and Grants Fast Track Designation for Cluster Headache Development Program
12/15/2017 - 08:17 Teva Announces Exclusive Launch of Generic Viread in the United States
12/14/2017 - 13:18 Teva Announces Restructuring Plan and Additional Measures to Improve Its Business and Financial Performance
12/13/2017 - 22:46 Teva to Host Conference Call to Discuss Restructuring Plan and Additional Measures to Improve Its Business and Financial Performance at 8:00 a.m. ET on December 14, 2017
12/11/2017 - 08:18 Teva Announces Exclusive Launch of Generic Viagra Tablets in the United States
11/29/2017 - 17:56 The New England Journal of Medicine Publishes Data from Pivotal Phase III Trial of Fremanezumab for the Preventive Treatment of Chronic Migraine
11/27/2017 - 11:01 Teva Announces New Organization Structure and Leadership Changes
11/02/2017 - 13:18 Teva Announces Completion of Plan B One-Step Divestiture to Foundation Consumer Healthcare
11/01/2017 - 14:45 Teva Announces Completion of PARAGARD Divestiture to CooperSurgical
10/31/2017 - 06:38 Teva Wins Generic Uceris Patent Trial
10/30/2017 - 13:54 Kare Schultz to Join Teva as President and Chief Executive Officer on November 1, 2017
10/19/2017 - 08:29 Teva to Highlight New Data in Multiple Sclerosis at Joint ECTRIMS ACTRIMS Congress in Paris
10/17/2017 - 09:09 Teva Announces Submission of Biologics License Application for Fremanezumab to the U.S. FDA
10/05/2017 - 07:30 Teva Announces tomys Award Winner at Oncology Satellite Symposium During the 7th International Symposium on Acute Promyelocytic Leukemia (APL) in Rome, Italy
10/04/2017 - 08:44 Teva Comments on Anticipated At-Risk U.S. Launch of Generic Glatiramer Acetate 40mg/mL and Launch of Generic Glatiramer Acetate 20mg/mL